Controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia "AICLA"

Completed

Phase N/A Results

Summary of Purpose

To determine whether aspirin or aspirin + dipyridamole would produce a significant reduction in the subsequent occurrence of fatal and nonfatal cerebral infarction.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 February 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, placebo-controlled trial of 604 patients.

Contacts

Not available